# Selecting Patients Who May Benefit From Immunotherapy by Tissue-based Biomarkers.

> **NCT05593419** · — · UNKNOWN · sponsor: **Peking University** · enrollment: 300 (estimated)

## Conditions studied

- Gastric Cancer Patients Received Immunotherapy

## Interventions

- **DEVICE:** TIIC signature

## Key facts

- **NCT ID:** NCT05593419
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-31
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05593419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05593419, "Selecting Patients Who May Benefit From Immunotherapy by Tissue-based Biomarkers.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05593419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*